CDC Panel Recommends MRNA Vaccines Over J&J

Roll Call reports:

Centers for Disease Control and Prevention vaccine advisers voted unanimously Thursday to recommend that the Johnson & Johnson COVID-19 vaccine take a back seat to Moderna and Pfizer shots, when possible, due to risks of adverse side effects.

Serious clotting events, specifically thrombosis with thrombocytopenia, or TTS, are a rare but serious side effect of the Johnson & Johnson COVID-19 vaccines.

The CDC Advisory Committee on Immunization Practices said the risks of the Johnson & Johnson vaccine do not necessarily outweigh its benefits, but when given an option, the benefit-risk balance leans toward mRNA vaccines across all age groups and sexes.

Read the full article.

The 15-0 vote is just the latest in a series of setbacks for the Johnson & Johnson COVID-19 vaccine. https://t.co/DUfCIiU4Lt

— Roll Call (@rollcall) December 17, 2021